The SRPT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SRPT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The SRPT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View SRPT Detailed Price Forecast - CNN Money||View SRPT Detailed Summary - Google Finance|
|View SRPT Detailed Summary - Yahoo! Finance||View SRPT Stock Research & Analysis - Zacks.com|
|View SRPT Trends & Analysis - Trade-Ideas||View SRPT Major Holders - Barrons|
|View SRPT Call Transcripts - NASDAQ||View SRPT Breaking News & Analysis - Seeking Alpha|
|View SRPT Annual Report - CompanySpotlight.com||View SRPT OTC Short Report - OTCShortReport.com|
|View SRPT Fundamentals - TradeKing||View SRPT SEC Filings - Bar Chart|
|View Historical Prices for SRPT - The WSJ||View Performance/Total Return for SRPT - Morningstar|
|View the Analyst Estimates for SRPT - MarketWatch||View the Earnings History for SRPT - CNBC|
|View the SRPT Earnings - StockMarketWatch||View SRPT Buy or Sell Recommendations - MacroAxis|
|View the SRPT Bullish Patterns - American Bulls||View SRPT Short Pain Metrics - ShortPainBot.com|
|View SRPT Stock Mentions - StockTwits||View SRPT Stock Mentions - PennyStockTweets|
|View SRPT Stock Mentions - Twitter||View SRPT Investment Forum News - Investor Hub|
|View SRPT Stock Mentions - Yahoo! Message Board||View SRPT Stock Mentions - Seeking Alpha|
|View Insider Transactions for SRPT - SECform4.com||View Insider Transactions for SRPT - Insider Cow|
|View SRPT Major Holdings Summary - CNBC||View Insider Disclosure for SRPT - OTC Markets|
|View Insider Transactions for SRPT - Yahoo! Finance||View Institutional Holdings for SRPT - NASDAQ|
|View SRPT Stock Insight & Charts - FinViz.com||View SRPT Investment Charts - StockCharts.com|
|View SRPT Stock Overview & Charts - BarChart||View SRPT User Generated Charts - Trading View|
See what the IHS Markit Score report has to say about Sarepta Therapeutics Inc.
Posted on Friday January 18, 2019
# Sarepta Therapeutics Inc ### NASDAQ/NGS:SRPT View full report here! ## Summary * Bearish sentiment is high and has been increasing ## Bearish sentiment Short interest | Negative Short interest is high for SRPT with between 15 and 20% of shares on loan. This means that investors who seek to profit from falling equity prices are currently targeting SRPT. Sentiment has worsened and traders added to their bearish short positions on January 16. ## Money flow ETF/Index ownership | Neutral ETF activity is neutral. The net inflows of $3.51 billion over the last one-month into ETFs that hold SRPT are not among the highest of the last year and have been slowing. ## Economic sentiment PMI by IHS Markit | Neutral According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to firstname.lastname@example.org. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Here are top analysts' 5 favorite growth stocks for 2019
Posted on Wednesday January 16, 2019
Even in these uncertain times, there are still compelling growth stocks to be found. These are TipRanks' five picks.
Here’s your guide to the upcoming biotechnology takeover wave
Posted on Tuesday January 15, 2019
Biotechnology companies have been hit so hard, Big Pharma is now picking them off one by one in takeovers. This makes biotech companies look very attractive. In the weakness, for example, Celgene (CELG) hit its lowest price-to-earnings ratio in history, or around six.
FDA pilot program could help Wave avoid orphan-drug pitfalls
Posted on Tuesday January 15, 2019
Wave will work with FDA officials during the pilot program to design a Phase 2-3 clinical trial with a reduced number of placebo patients, tweaking standards that have stymied other rare disease products.